发布求助
文献互助 智能选刊 最新文献

Clinical ovarian cancer and other gynecologic malignancies最新文献

筛选
英文 中文
2022-RA-800-ESGO AGO-OVAR 27: window-of-opportunity proof-of-concept, non-randomized, open-label phase ii trial of olaparib given alone or in combination with durvalumab prior to primary debulking surgery in histologically proven high-grade epithelial ovarian cancer 2022-RA-800-ESGO AGO-OVAR 27:机会之窗概念验证，非随机，开放标签ii期试验，在组织学证实的高级别上皮性卵巢癌的原发性减体积手术前单独给予奥拉帕尼或与杜伐单抗联合
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.563
F. Marmé, F. Heitz, P. Harter, A. Reuss, Friederike Kipkeew, P. Wimberger, H. Bronger, A. Bois, J. Sehouli, F. Hilpert
{"title":"2022-RA-800-ESGO AGO-OVAR 27: window-of-opportunity proof-of-concept, non-randomized, open-label phase ii trial of olaparib given alone or in combination with durvalumab prior to primary debulking surgery in histologically proven high-grade epithelial ovarian cancer","authors":"F. Marmé, F. Heitz, P. Harter, A. Reuss, Friederike Kipkeew, P. Wimberger, H. Bronger, A. Bois, J. Sehouli, F. Hilpert","doi":"10.1136/ijgc-2022-esgo.563","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.563","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82994637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1295-ESGO The role of intraoperative indocyanine green fluorescence angiography in preventing anastomotic leakage after colorectal resection for advanced ovarian cancer 术中吲哚菁绿荧光血管造影在预防晚期卵巢癌结直肠癌术后吻合口漏中的作用
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.681
G. Schivardi, A. Ciobanu, Andrea Dell'Acqua, L. D. De Vitis, G. Bonaldo, I. Betella, M. Achilarre, A. Aloisi, A. Garbi, A. Mariani, N. Colombo, V. Zanagnolo, A. Maggioni, R. Biffi, F. Multinu, G. Aletti
{"title":"2022-RA-1295-ESGO The role of intraoperative indocyanine green fluorescence angiography in preventing anastomotic leakage after colorectal resection for advanced ovarian cancer","authors":"G. Schivardi, A. Ciobanu, Andrea Dell'Acqua, L. D. De Vitis, G. Bonaldo, I. Betella, M. Achilarre, A. Aloisi, A. Garbi, A. Mariani, N. Colombo, V. Zanagnolo, A. Maggioni, R. Biffi, F. Multinu, G. Aletti","doi":"10.1136/ijgc-2022-esgo.681","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.681","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84074859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
2022-RA-1348-ESGO Role of computed tomography (CT) scan based reporting system ‘PAUSE’ to predict surgical resectability in epithelial ovarian cancer 基于计算机断层扫描(CT)报告系统“PAUSE”在预测上皮性卵巢癌手术可切除性中的作用
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.696
Seema Singhal, Atul Sharma, E. Dhamija, Sunesh Kumar, J. Meena, R. Kumari, Anju Singh, Sarita Kumari, J. Natarajan, Anu Sabarinath, A. Mandal, Rudrika Chandra, Romey Rai, Dipanwita Banerjee, Swati Tomar, S. Mathur, N. Bhatla
{"title":"2022-RA-1348-ESGO Role of computed tomography (CT) scan based reporting system ‘PAUSE’ to predict surgical resectability in epithelial ovarian cancer","authors":"Seema Singhal, Atul Sharma, E. Dhamija, Sunesh Kumar, J. Meena, R. Kumari, Anju Singh, Sarita Kumari, J. Natarajan, Anu Sabarinath, A. Mandal, Rudrika Chandra, Romey Rai, Dipanwita Banerjee, Swati Tomar, S. Mathur, N. Bhatla","doi":"10.1136/ijgc-2022-esgo.696","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.696","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78052714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-688-ESGO Survival outcomes of advanced ovarian cancer patients undergoing maximal effort cytoreduction 最大努力细胞减少的晚期卵巢癌患者的生存结局
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.547
E. Zachariou, V. Pergialiotis, Ioakim Sapantzoglou, I. Prokopakis, N. Thomakos, N. Alexakis, A. Rodolakis, D. Haidopoulos
{"title":"2022-RA-688-ESGO Survival outcomes of advanced ovarian cancer patients undergoing maximal effort cytoreduction","authors":"E. Zachariou, V. Pergialiotis, Ioakim Sapantzoglou, I. Prokopakis, N. Thomakos, N. Alexakis, A. Rodolakis, D. Haidopoulos","doi":"10.1136/ijgc-2022-esgo.547","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.547","url":null,"abstract":". Primary endpoint: investiga-tor-assessed progression-free survival (RECIST v1.1) in the nemvaleukin+pembrolizumab versus chemotherapy arms. Secondary/exploratory endpoints include overall survival, other anti-tumour measures, safety, health-related quality of life, and pharmacokinetic/pharmacodynamic effects. Results","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81750775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1305-ESGO Over-expression of multimerin1 protein in ovarian cancer progression 2022-RA-1305-ESGO多聚蛋白1在卵巢癌进展中的过表达
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.682
S. Yadav, A. Saini, K. Chandra, Vikrant Kumar, S. Mathur, J. Sharma, Alpana Sharma
{"title":"2022-RA-1305-ESGO Over-expression of multimerin1 protein in ovarian cancer progression","authors":"S. Yadav, A. Saini, K. Chandra, Vikrant Kumar, S. Mathur, J. Sharma, Alpana Sharma","doi":"10.1136/ijgc-2022-esgo.682","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.682","url":null,"abstract":"2022-RA-1306-ESGO Figure 1 Abstract 2022-RA-1306-ESGO Table 1 Patient, tumor and treatment characteristics Abstracts2022-RA-1306-ESGO Table 1 Patient, tumor and treatment characteristics Abstracts A320 Int J Gynecol Cancer 2022;32(Suppl 2):A1–A504 on D ecem er 6, 2022 by gest. P rocted by coright. http/ijgc.bm jcom / nt J G ynecol C acer: frst pulished as 10.11ijgc-2022-E S G O .82 on 20 O cber 222. D ow nladed fom","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"340 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76391593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-728-ESGO High expression of vacuolar-ATPase subunit ATP6V1B1 predicts a poor prognosis and correlates with cell cycle progression in epithelial ovarian cancer 液泡- atp酶亚基ATP6V1B1的高表达预示着上皮性卵巢癌的不良预后并与细胞周期进展相关
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.553
Hee Yun, Gwan Hee Han, H. Kim, Hanbyoul Cho, Sunghoon Kim, Jae-Hoon Kim
{"title":"2022-RA-728-ESGO High expression of vacuolar-ATPase subunit ATP6V1B1 predicts a poor prognosis and correlates with cell cycle progression in epithelial ovarian cancer","authors":"Hee Yun, Gwan Hee Han, H. Kim, Hanbyoul Cho, Sunghoon Kim, Jae-Hoon Kim","doi":"10.1136/ijgc-2022-esgo.553","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.553","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83910670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-456-ESGO Gynae-oncology surgeons’ preparedness to undertake colorectal procedures during cytoreductive surgery for ovarian cancer: a cross sectional survey 妇科肿瘤外科医生在卵巢癌细胞减少手术期间进行结直肠手术的准备:一项横断面调查
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.510
D. Huddart, S. Rajkumar, G. Mehra, R. Nath, A. Sayasneh
{"title":"2022-RA-456-ESGO Gynae-oncology surgeons’ preparedness to undertake colorectal procedures during cytoreductive surgery for ovarian cancer: a cross sectional survey","authors":"D. Huddart, S. Rajkumar, G. Mehra, R. Nath, A. Sayasneh","doi":"10.1136/ijgc-2022-esgo.510","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.510","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"85 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83922296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-173-ESGO Endometrioid borderline ovarian tumor: clinical characteristics, prognosis and management 2022-RA-173-ESGO子宫内膜样交界性卵巢肿瘤的临床特点、预后及治疗
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.480
G. Ricotta, A. Maulard, S. Gouy, A. Leary, P. Pautier, P. Morice
{"title":"2022-RA-173-ESGO Endometrioid borderline ovarian tumor: clinical characteristics, prognosis and management","authors":"G. Ricotta, A. Maulard, S. Gouy, A. Leary, P. Pautier, P. Morice","doi":"10.1136/ijgc-2022-esgo.480","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.480","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"35 Pts 1-2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82670523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-883-ESGO Rare Cancers in Gynecologic Oncology, ENGOT initiative for a European Registry 2022-RA-883-ESGO妇科肿瘤罕见癌症，ENGOT倡议欧洲注册
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.582
L. Ceppi, A. Bergamini, E. Biagioli, O. Solheim, A. González-Martín, N. Ottevanger, E. Van Nieuwenhuysen, A. Hasenburg, K. Cadoo, E. Braicu, M. Hall, D. Bauerschlag, S. Aust, R. Glasspool, C. Lok, J. Korach, D. Cibula, S. Pignata, I. Ray-Coquard
{"title":"2022-RA-883-ESGO Rare Cancers in Gynecologic Oncology, ENGOT initiative for a European Registry","authors":"L. Ceppi, A. Bergamini, E. Biagioli, O. Solheim, A. González-Martín, N. Ottevanger, E. Van Nieuwenhuysen, A. Hasenburg, K. Cadoo, E. Braicu, M. Hall, D. Bauerschlag, S. Aust, R. Glasspool, C. Lok, J. Korach, D. Cibula, S. Pignata, I. Ray-Coquard","doi":"10.1136/ijgc-2022-esgo.582","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.582","url":null,"abstract":"collaborative group. Periodi-cal meetings were set up in order to update the ENGOT rare tumor working group on database development and share critical points. Results The survey showed an interest in adopting the database in 94.4% of responders. The database has been developed, revised by a reviewers committee, and shared for data entry. Conclusion National collaborative groups will participate inde-pendently in setting up a REDCap-based database with the same database structure. A central ENGOT coordination will ensure the appropriate data entry and registry management for future data analysis. This project will allow improving the knowledge of these rare cancers in Europe","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"98 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82792030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-466-ESGO Long-term responders (LTR) to rucaparib in recurrent ovarian cancer: a sub-group analysis from the rucaparib access (RAP) program in Spain by GEICO 复发性卵巢癌对rucaparib的长期应答者(LTR):来自西班牙GEICO的rucaparib准入(RAP)项目的亚组分析
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.513
A. Yubero, Aránzazu Barquín, L. Gaba, B. Pajares, Piedad Reche, C. Salvador, J. Alarcón, L. Manso, R. Márquez, José Fuentes, J. Madani, Manuel Costenla, María Gutiérrez-Toribio, P. Estévez-García, A. Santaballa, L. Sánchez-Lorenzo, J. Calzas, A. Herrero, Á. Taus, A. González-Martín
{"title":"2022-RA-466-ESGO Long-term responders (LTR) to rucaparib in recurrent ovarian cancer: a sub-group analysis from the rucaparib access (RAP) program in Spain by GEICO","authors":"A. Yubero, Aránzazu Barquín, L. Gaba, B. Pajares, Piedad Reche, C. Salvador, J. Alarcón, L. Manso, R. Márquez, José Fuentes, J. Madani, Manuel Costenla, María Gutiérrez-Toribio, P. Estévez-García, A. Santaballa, L. Sánchez-Lorenzo, J. Calzas, A. Herrero, Á. Taus, A. González-Martín","doi":"10.1136/ijgc-2022-esgo.513","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.513","url":null,"abstract":"The proposed test is a viable alternative to the Myriad myChoice HRD test and can easily be implemented in a clinical laboratory for routine practice. The performance of the tests is similar in terms of hazard ratio but the lower failure rate of the Geneva HRD test allows a 10% increase in the number of patients receiving a conclusive laboratory result.","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83077254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书